Trump signs order on psychedelic treatments

President Donald Trump has signed an Executive Order aimed at accelerating medical research and patient access to psychedelic-based treatments. The order targets conditions including PTSD, traumatic brain injury, depression, anxiety, and addiction. This move represents a significant federal policy shift towards exploring alternative therapies for mental health and neurological disorders. It directs relevant agencies to streamline regulatory pathways and support clinical development in this emerging field.